“Global Clinical Risk Grouping Solution Market to reach a market value of 1.7 Billion by 2031 growing at a CAGR of 12.9%”
The Global Clinical Risk Grouping Solution Market size is expected to reach $1.7 billion by 2031, rising at a market growth of 12.9% CAGR during the forecast period.
China is also facing a rapidly aging population. The National Bureau of Statistics of China reports that the proportion of Chinese individuals aged 60 or older in the country's total population was 18.7 percent in 2021, 5.44 percentage points higher than the previous census data in 2010. This demographic change contributes to a rise in chronic diseases and the demand for more intensive healthcare services. In response, Chinese healthcare providers are increasingly adopting clinical risk grouping solutions to better manage the healthcare needs of the elderly. Thus, the Asia Pacific region acquired 23% revenue share in the market 2023.
The major strategies followed by the market participants are Product Launch as the key developmental strategy to keep pace with the changing demands of end users. For instance, In October, 2024, Oracle announces new enhancements to its Oracle Fusion Cloud Applications Suite, specifically within SCM, HCM, and ERP, designed to help healthcare organizations optimize operations, reduce costs, and improve patient care by streamlining processes and empowering employees. Additionally, In 2023, September, Nuance Communications, a Microsoft company, has launched Dragon Ambient eXperience (DAX™) Copilot, an AI tool for automated clinical documentation. It uses advanced AI to streamline medical documentation, enhance clinical efficiency, reduce burnout, and allow physicians to focus on patient care.
Based on the Analysis presented in the KBV Cardinal matrix; Microsoft Corporation is the forerunner in the Enterprise Key Management Market. Companies such as Health Catalyst, Inc. and Koninklijke Philips N.V. are some of the key innovators in Enterprise Key Management Market. In October, 2023, Microsoft Corporation is introducing AI-driven capabilities to help clinicians access and organize patient data, such as chronological patient timelines. These enhancements aim to improve healthcare operations by making crucial information more readily available to frontline clinicians.
The data typically used in clinical risk grouping—derived from regular patient interactions, chronic disease management, and routine screenings—became less reliable or less available. This disruption made it difficult for healthcare providers to maintain the accuracy and relevance of their risk stratification models, as the patient data pool became skewed toward COVID-19-related cases. The focus on pandemic response also meant that ongoing training and implementation efforts for clinical risk grouping solutions were delayed or suspended, further slowing market growth.
These solutions analyze various data points, including medical history, lifestyle factors, and genetic predispositions, to stratify patients based on their risk levels. By accurately identifying high-risk patients, healthcare providers can implement targeted interventions that are more likely to prevent complications, reduce hospitalizations, and improve overall patient outcomes. Hence, the growing prevalence of chronic diseases has created a critical demand for clinical risk grouping solutions.
Additionally, cloud-based AI-powered platforms can be deployed across large healthcare networks, providing consistent and reliable risk assessments regardless of location. This scalability is essential for standardizing care across multiple facilities, ensuring that all patients benefit from the latest advancements in risk management. Thus, as AI advances, its impact on clinical risk grouping will likely expand.
Healthcare organizations must ensure that any new technology complies with these regulations, which can be complex and time-consuming. The fear of non-compliance and the associated penalties make providers even more cautious about adopting clinical risk grouping solutions. Hence, deploying clinical risk grouping solutions is often slowed down due to these data privacy and security concerns.
The leading players in the market are competing with diverse innovative offerings to remain competitive in the market. The above illustration shows the percentage of revenue shared by some of the leading companies in the market. The leading players of the market are adopting various strategies in order to cater demand coming from the different industries. The key developmental strategies in the market are Acquisitions, and Partnerships & Collaborations.
Based on product, the market is bifurcated into software and services. The services segment procured 30% revenue share in the market in 2023. This segment includes a range of offerings such as implementation support, training, maintenance, and ongoing technical assistance.
On the basis of end-use, the market is classified into hospitals & clinics, ambulatory surgical centers, long term care centers, and others. The hospitals & clinics segment acquired 46% revenue share in the market in 2023. Clinical risk grouping solutions are employed extensively in these contexts to manage diverse and complex patient populations, which is the primary reason for their dominance.
By deployment, the market is divided into private cloud, public cloud, and hybrid cloud. The public cloud segment garnered 29% revenue share in the market in 2023. The appeal of public cloud deployments lies in their cost-effectiveness, scalability, and ease of implementation.
Based on application, the market is segmented into population health management, chronic disease management, clinical decision support, fraud detection & prevention, and others. The population health management segment procured 40% revenue share in the market in 2023. This dominance is driven by the increasing focus on improving health outcomes for entire populations, particularly in value-based care models.
Free Valuable Insights: Global Clinical Risk Grouping Solution Market size to reach USD 1.7 Billion by 2031
Region-wise, the Clinical Risk Grouping Solution Market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment witnessed 29% revenue share in the Clinical Risk Grouping Solution Market in 2023. The region's mature industrial base, stringent regulatory environment, and high product quality and safety standards drive the demand for TIC services.
The clinical risk grouping solution market is competitive with key players like Microsoft Corporation leading the field. Key attributes include advanced analytics, integration capabilities, and accuracy in risk stratification. Competition is driven by the demand for improved patient outcomes, regulatory compliance, and cost reduction. Providers differentiate through features like predictive analytics, customizable risk models, and seamless integration with electronic health records (EHRs), addressing the growing need for effective risk management in healthcare.
| Report Attribute | Details |
|---|---|
| Market size value in 2023 | USD 643.2 Million |
| Market size forecast in 2031 | USD 1.7 Billion |
| Base Year | 2023 |
| Historical Period | 2020 to 2022 |
| Forecast Period | 2024 to 2031 |
| Revenue Growth Rate | CAGR of 12.9% from 2024 to 2031 |
| Number of Pages | 291 |
| Number of Tables | 463 |
| Report coverage | Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Competitive Landscape, Market Share Analysis, Porter’s 5 Forces Analysis, Company Profiling, Companies Strategic Developments, SWOT Analysis, Winning Imperatives |
| Segments covered | Product, End Use, Deployment, Application, Region |
| Country scope |
|
| Companies Included | Conduent, Incorporated, 3M Company, Oracle Corporation (Cerner Corporation), Microsoft Corporation (Nuance Communications, Inc.), Health Catalyst, Inc., Koninklijke Philips N.V., Siemens Healthineers AG (Siemens AG), HBI Solutions, Lightbeam Health Solutions and Reveleer |
By Product
By End-use
By Deployment
By Application
By Geography
This Market size is expected to reach $1.7 billion by 2031.
Growing prevalence of chronic diseases are driving the Market in coming years, however, Data privacy and security concerns restraints the growth of the Market.
Conduent, Incorporated, 3M Company, Oracle Corporation (Cerner Corporation), Microsoft Corporation (Nuance Communications, Inc.), Health Catalyst, Inc., Koninklijke Philips N.V., Siemens Healthineers AG (Siemens AG), HBI Solutions, Lightbeam Health Solutions and Reveleer
The expected CAGR of this Market is 12.9% from 2024 to 2031.
The Software segment is leading the Market by Product in 2023; thereby, achieving a market value of $1.2 billion by 2031.
The North America region dominated the Market by Region in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $682.3 million by 2031.
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 